Sanofi/Regeneron’s Dupixent: A First For COPD, But Not The Last

copd
Dupixent was approved to treat COPD in the US • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Respiratory

More from Therapy Areas